Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem presented as a sterile powder for reconstitution for intravenous use. It treats severe bacterial infections, including intra‑abdominal, skin and soft‑tissue, and respiratory infections, in hospitalized adult and pediatric patients. It is indicated for infections caused by susceptible Gram‑negative and Gram‑positive organisms and is administered under medical supervision.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product meets European Union quality standards and is distributed through GNH USA's regulated supply chain to ensure product integrity.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections.

- Complicated intra‑abdominal infections: effective in eradicating susceptible pathogens and resolving infection. - Complicated skin and soft‑tissue infections: provides rapid bacterial clearance and promotes wound healing. - Community‑acquired pneumonia: achieves high pulmonary concentrations to combat resistant organisms. - Hospital‑acquired pneumonia: targets multidrug‑resistant Gram‑negative bacteria in critical care settings. - Sepsis: delivers bactericidal activity essential for systemic infection control. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis caused by susceptible strains.

Adverse reactions may occur with any antibiotic therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional emesis, often self‑limiting. - Diarrhea: may range from loose stools to mild colitis. - Headache: transient cranial discomfort. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient hepatic enzyme rise.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile colitis: severe diarrhea with pseudomembranous colitis. - Anaphylaxis: acute hypersensitivity requiring emergency care. - Renal impairment: acute kidney injury in susceptible individuals. - Severe hypersensitivity reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hemolytic anemia: rare immune‑mediated red cell destruction.

Careful assessment and monitoring are required before and during therapy.

- Renal function assessment: adjust dose in patients with reduced clearance. - Seizure risk monitoring: avoid in patients with a history of epilepsy or CNS disorders. - Hepatic impairment caution: monitor liver function tests during prolonged use. - Hypersensitivity screening: discontinue if signs of allergic reaction appear. - Valproic acid interaction: avoid concomitant use as meropenem can lower valproate levels. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: significant reduction of serum valproate concentrations. - Phenobarbital: decreased meropenem efficacy due to enzyme induction. - Other carbapenems: additive toxicity, especially neurotoxicity. - Aminoglycosides: increased risk of nephrotoxicity when combined.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - NSAIDs: watch for renal impairment. - Warfarin: observe INR for potential anticoagulation changes. - Oral contraceptives: possible reduced effectiveness, consider backup method.